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Abstract
Background Boerhaave’s syndrome has a high mortality
rate (14–40%). Surgical treatment varies from a minimal
approach consisting of adequate debridement with drainage
of the mediastinum and pleural cavity to esophageal
resection. This study compared the results between a pre-
viously preferred open minimal approach and a video-
assisted thoracoscopic surgery (VATS) procedure currently
considered the method of choice.
Methods In this study, 12 consecutive patients treated
with a historical nonresectional drainage approach
(1985–2001) were compared with 12 consecutive patients
treated prospectively after the introduction of VATS during
the period 2002–2009. Baseline characteristics were
equally distributed between the two groups.
Results In the prospective group, 2 of the 12 patients had
the VATS procedure converted to an open thoracotomy,
and 2 additional patients were treated by open surgery. In
the prospective group, 8 patients experienced postoperative
complications compared with all 12 patients in the histor-
ical control group. Four patients (17%), two in each group,
underwent reoperation. Six patients, three in each group,
were readmitted to the hospital. The overall in-hospital
mortality was 8% (1 patient in each group), which com-
pares favorably with other reports (7–27%) based on
drainage alone.
Conclusions Adequate surgical debridement with drain-
age of the mediastinum and pleural cavity resulted in a low
mortality rate. The results for VATS in this relatively small
series were comparable with those for an open
thoracotomy.
Keywords Esophageal perforation  Esophagus 
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Spontaneous rupture of the esophagus, ﬁrst described by
Boerhaave in 1724 [1], is a life-threatening condition
characterized by a disruption of the distal esophagus due to
a barotrauma that results in contamination of the medias-
tinum and pleural cavity with gastric contents. Boerhaave’s
syndrome is rare, and the exact incidence is not known.
Often, a signiﬁcant delay occurs between perforation and
treatment, leading to chemical and bacterial mediastinitis
followed by sepsis and multiorgan failure.
Most studies describe a high mortality rate of 14% to
40% [2–6]. Surgical treatment still is controversial, ranging
from a less invasive approach consisting of adequate
debridement and drainage of the mediastinum and pleural
cavity followed by continued postoperative rinsing to
resection of the thoracic esophagus.
Since 1985, we have acquired a large experience with
the drainage procedure, which is our preferred method [7].
Until 2001, we established drainage by mediastinal wid-
ening through an open thoracotomy. After the introduction
of video-assisted thoracoscopic surgery (VATS), it was
found theoretically that thoracotomy added signiﬁcant
surgical trauma and pain, likely impairing postoperative
recovery. Therefore, when VATS emerged, we changed
our already less aggressive nonresectional approach in
2002 to this less invasive technique. Since 2002, we have
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morbidity for these vulnerable patients.
In this study, we compared the early and late results of
the nonresection drainage procedure between patients
treated by VATS and a historical control group treated by
thoracotomy.
Materials and methods
Patients
From January 2002 through October 2009, we prospec-
tively treated 12 consecutive Boerhaave’s syndrome
patients with nonresection drainage using the VATS
approach. All data were collected from the medical records
according to the rules of our institutional ethics committee.
Patient characteristics, pre- and intraoperative data, post-
operative management, and outcome were retrospectively
analyzed. This prospective group was compared with 12
patients from a previously described historical control
group treated from 1985 through 2001 [7].
Treatment strategy
The diagnosis was conﬁrmed by chest X-ray, computed
tomography (CT) of the thorax and abdomen, and occa-
sionally, a contrast esophagographic examination. The
X-rays and CT scans were evaluated for the presence of
pneumomediastinum, pneumothorax, or leakage in the
mediastinum or pleural cavity. Contrast studies may con-
ﬁrm extravasation outside the esophagus. Patients were
promptly treated with broad-spectrum antibiotics, subse-
quently narrowed according to the results of cultures from
collected mediastinal or pleural ﬂuid obtained during
puncture or surgery and from blood cultures.
During surgery, patients were intubated with a double-
lumen tube for selective ventilation. Based on the perfo-
ration site and intrathoracic ﬂuid collections, we decided to
use either a left- or right-sided surgical approach. Because
most patients presented with a distal rupture, the left sur-
gical approach was commonly used. The surgical princi-
ples were more or less equal for the patients treated with
thoracotomy or the VATS procedure.
After selective lung ventilation, the posterior mediasti-
num was opened, and a meticulous irrigation with evacu-
ation of food debris and necrosis was accomplished.
Occasionally, the rupture was sutured, but the esophagus
was never resected or diverted. For continuous postopera-
tive irrigation, an Axiom
 suction drain (Sigma Medical,
Apeldoorn, the Netherlands) was attached to the tip of a
Foley catheter for irrigation at the perforation site in the
mediastinum, and a thoracic chest tube was placed for
passive drainage. A thoracotomy usually was performed
through an incision of the seventh intercostal space on the
left or through the ﬁfth intercostal space on the right.
For VATS, a total of four trocars were inserted. First, the
12-mm camera port was introduced in the seventh or eighth
intercostal space at the midaxillary line. A 30 angled rigid
endoscope was used. Another 12-mm port was introduced at
the third or fourth intercostal space for the endoscopic
retractor.Two5-mm ports wereplacedmore cranially,one at
the midaxillary line in the fourth intercostal space and one in
the subscapular area accommodating a blunt grasper and
suction/irrigation device. Since 2002, a ruptured esophagus
has been preferably treated by the VATS technique and con-
verted to a thoracotomy in case of adhesions or poor visuali-
zation.Alltheseoperationswereperformedorsupervisedbya
staff surgeon with experience in esophageal surgery.
Postoperatively, patients were stimulated to drink water
in addition to the external irrigation process. Early enteral
nutrition was started through a nasojejunal tube. The
esophageal rupture was considered healed when leakage
was neither found on contrast studies nor present in
mediastinal drains after orally administered methylene blue
dye. In case of conversion to an open procedure, a surgical
jejunostomy was included. Postoperative complications,
length of intensive care unit (ICU) and hospital stay, and
time to esophageal healing were recorded.
Statistical analysis
Data are presented as median and range. In case of cate-
gorical data, the number of patients are presented. Differ-
ences between categorical variables were tested with
Fisher’s exact test. The Mann–Whitney U test was per-
formed to calculate differences in continuous variables.
Results
Patients and procedures
Patient characteristics are presented in Table 1. None of
the 24 patients were treated by resection or cervical
esophagostomy. No signiﬁcant differences in demographic
data were found between the two groups. Referrals from
another hospital included 9 of the 12 patients in the pro-
spective group and 5 of the 12 patients in the control group.
As shown, some of the patients had a long delay between
the start of symptoms and surgery. The apparent reasons
for this delay were the diagnosis and referral of patients
with Boerhaave’s syndrome.
In the prospective group, 10 patients were treated by
VATS. Two of these patients underwent conversion to a
thoracotomy because of inadequate visualization. For
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123another two patients, VATS was not performed as the
primary treatment method. In one patient, the rupture was
more caudal at the abdominal esophagus and amenable by
laparotomy and transhiatal access to the posterior medias-
tinum. Chest tubes were inserted separately. The remaining
patient was treated by a left thoracoabdominal approach
because the operating surgeon did not have sufﬁcient
experience with the VATS technique.
Primary closure of the esophageal perforation was per-
formed for two patients in the historical control group, both
within 12 h after initial symptoms. It was successful for the
one patient, but the other patient experienced osteomyelitis
with ﬁstula, leading to several reoperations.
In the historical control group, four patients were treated
initially by conservative measures consisting of broad-
spectrum antibiotics, cessation of oral intake, nasogastric
aspiration for gastric decompression, and chest drainage of
the pleural cavity. This treatment failed for all these
patients after 3, 4, 6 and 57 days because of pleural
empyema, and they subsequently underwent thoracotomy.
Unfortunately, one of these patients died of sepsis.
Postoperative complications, reinterventions,
and readmissions
Postoperative data are presented in Table 2. Table 3 pre-
sents postoperative complications and readmissions. Four
patients underwent reoperation, two in each group. One of
these patients in the prospective group had a relaparotomy
because of leakage from the jejunostomy that was over-
sewn after performance of a new jejunostomy. For the
remaining patient in this group, a right-sided VATS pro-
cedure was performed 11 days after an initial left-sided
thoracotomy because of inadequate drainage. In the his-
torical control group, one patient experienced a ﬁstula with
osteomyelitis of the rib. After debridement and ﬁstulec-
tomy had been performed, a costal resection with a
latissimus dorsi reconstruction was needed. The remaining
patient experienced pleural empyema followed by a
rethoracotomy with chest drainage.
In the prospective group; 8 of the 12 patients experi-
enced one or more complications. The complications
resulted in death for one patient with a Karnofsky score of
50%, pneumonia for two ICU patients, readmission for one
patient, and postoperative delirium for three patients.
Pleural empyema occurred for three patients, followed by a
re-VATS for one of the patients to drain the empyema. For
two patients, CT-guided drainage could be performed. One
patient had leakage of the surgical jejunostomy.
All patients in the historical group experienced one or
more complications, including sepsis and death for one
patient, pneumonia for three patients leading to ICU
readmission for one patient, pleural empyema for one
patient, postoperative delirium for ﬁve patients, peptic
Table 1 Patient characteristics
and intraoperative data
The differences were not
signiﬁcant
a Data not available for 3
patients
Period 1987–2001 2002–2009 p Value
No. of patients 12 12
Median age: years (range) 51 (27–70) 62 (45–70) 0.241
Males 7 11 0.417
Median time between start of symptoms
and surgery: h (range)
72 (10–1344)
a 44 (9–264) 0.426
No. of patients receiving surgery
in\24 h
4
a 5 0.480
Intraoperative data
Right sided perforations 5 5
Left sided perforations 7 7
Table 2 Postoperative data
Period 1987–2001 2002–2009 p Value
No. of patients 12 12
Postoperative data: median
(range)
APACHE-II score
a NA 9 (3–16) –
Days of mechanical ventilation 6 (0–12)
b 8 (0–77) 0.219
Days of hemodynamic support
c NA 1 (0–23) –
Days to spontaneous closure 21 (1–326) 30
(17–231)
0.197
ICU stay (days) 9 (1–26) 13 (0–78) 0.151
Hospital stay (days) 46 (9–165) 52
(22–121)
0.949
APACHE acute physiology and chronic health evaluation, NA not
available
The differences were not signiﬁcant. Data were not available for 3
patients in the historical control group
a APACHE-II [15]. For one patient of the prospective group, this was
not available because the patient was not admitted to the intensive
care unit (ICU)
b Data not available for 3 patients
c Number of days the patient needed hemodynamic support by nor-
epinephrine or dopamine, for example
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123ulcer bleeding for one patient and esophageal ﬁstula and
renal failure for one patient.
Six patients were readmitted after discharge, three in
each group. In the prospective group, two patients had
fever and pleural empyema, and a CT-guided drainage was
performed. The remaining patient had fever and an
obstructed drain, which was changed. In the historical
control group, one patient was readmitted four times for
successful treatment of an esophagus ﬁstula with osteo-
myelitis. One patient was readmitted with pneumonia, and
antibiotic treatment was given. Another patient experi-
enced pleural empyema followed by a successful
reoperation.
In all the patients, the esophageal rupture healed with
drainage only. One patient in the prospective group had
active human immunodeﬁciency virus (HIV) (CD4
0.73 9 109/l, reference value 0.40–1.30 and CD8
1.14 9 109/l, reference value 0.20–0.70), and healing was
accomplished after 33 weeks. For one patient with osteo-
myelitis in the historical group, the esophageal ﬁstula
closed spontaneously after 45 weeks.
Mortality and follow-up evaluation
The in-hospital mortality was 8% (2 patients). In the pro-
spective group, one patient died of respiratory failure
shortly after discharge from the ICU on postoperative day
39. She had a poor Karnofsky performance score [8] of less
than 50% and a history of myocardial infarction, cerebro-
vascular disease, and diabetes mellitus. The remaining
patient in the historical group died of septic shock 2 days
after surgery when initial conservative treatment failed.
Additionally, one patient in the prospective group died of a
hepatocellular carcinoma during the follow-up period
29 months after discharge, and one patient in the historical
group died of a lymphoma 15 years later. In the historical
control group, one patient experienced esophageal stric-
ture, which was treated by several dilations. No other long-
term complications were observed.
Discussion
This study shows that adequate surgical drainage of the
mediastinum and pleural cavity is the main treatment for
Boerhaave’s syndrome. The relatively low in-hospital
mortality of 8% compares favorably with the 14% to 40%
mentioned in the literature [2–6]. Although the complica-
tion rate in this study still was relatively high, the results of
VATS were comparable with those for open thoracotomy.
Treating patients with a Boerhaave’s syndrome is
commonly associated with a high complication rate. Often,
there is delay in the diagnosis, so these patients frequently
are in a septic condition at surgery. In our opinion, ade-
quate surgical drainage with removal of food remnants and
necrotic tissue from the mediastinum and pleural cavity is
the mainstay of treatment. To minimize additional surgical
trauma for these already critically ill patients, no attempt
should be made either to suture the rupture or to resect the
esophagus with cervical esophagostomy. After surgery,
irrigation of the chest is initiated.
In the historical control group, we initiated conservative,
nonoperative treatment by drainage of only the pleural
cavity with a thoracic drain for three patients, but this
strategy failed. One of these patients died of septic shock
shortly after surgery.
Other authors also have described results for nonsurgical
treatment of patients with Boerhaave’s syndrome [3, 9].
The mortality rates in the two cited studies ranged from 7%
to 27%. In the study by Vogel et al. [9], 3 of 13 patients
treated conservatively by radiologic chest tube drainage
underwent delayed surgical drainage.
We believe removal of food particles and debris is best
performed by surgery at an early stage. To abandon sur-
gical drainage and perform radiologic drainage is con-
ceivable only for patients with iatrogenic perforation of the
esophagus but no gross contamination of the mediastinum
with large food particles. Generally, these circumstances
are not present in Boerhaave’s syndrome. Another option is
to seal the perforation site with a covered metallic stent.
Siersema et al. [10] described ﬁve patients with
Boerhaave’s syndrome treated by esophageal stenting and
drainage of the mediastinum by chest tubes. One of these
patients had a very complicated course, with four reoper-
ations, resulting in esophageal resection with colon inter-
position [10].
We think that stenting of the esophagus alone could be a
good option for iatrogenic perforation. However, in case of
a contaminated mediastinum and pleural cavity with food
Table 3 Postoperative complications, reoperations, and readmissions
Period 1987–2001 2002–2009
No. of patients 12 12
Postoperative complications
a
Reoperation 2 2
Pleural empyema 1 3
Pneumonia 3 2
Delirium 5 3
Esophagus ﬁstula 1 0
Others 3 1
Total patients with complications 12 8
Readmissions 3 3
a Data are presented as number of patients. Some patients experi-
enced more than one complication
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bining stenting with an adequate surgical drainage of the
mediastinum and pleural cavity.
Many authors advise suturing the esophagus in case of
early surgery (\12–48 h). It should be kept in mind that this
approach has a relatively high chance of suture line leakage
because of the already necrotic region at the perforation
edges. In case of delayed surgery, other authors advise
complete resection of the esophagus with esophagostomy,
gastrostomy, and delayed reconstruction [5, 6, 11, 12].
In our opinion, esophageal resection for these critically
ill patients increases the surgical trauma and subsequent
inﬂammatory response, leading to more short- and long-
term complications. Furthermore, the additional delayed
nonphysiologic reconstructive surgery certainly is not a
minor procedure and could have an adverse effect on the
daily life of these patients.
Our experience with VATS for adequate surgical
debridement and drainage of the mediastinum shows that
this approach is effective by minimizing additional surgical
trauma in these already very ill patients. Previous studies
investigating VATS included only patients with iatrogenic
esophageal perforations [13, 14]. However, it is known that
iatrogenic perforations generally have fewer complications
than Boerhaave’s syndrome because the mediastinum and
pleural cavity are less severely contaminated.
Our study showed that VATS could be used as the ﬁrst
choice for Boerhaave’s syndrome. It is a safe procedure
with a complication rate and results the same as those for
open surgery. Because this report describes our initial
experience with VATS for Boerhaave’s syndrome, the
number of conversions to open surgery and the number of
patients with Boerhaave’s syndrome still treated with tho-
racotomy likely will decline with increasing experience,
which may show the theoretical advantages of VATS over
thoracotomy. To our knowledge, this is the ﬁrst study to
describe VATS treatment of patients with Boerhaave’s
syndrome.
Our study had its limitations. Because 13 of the patients
were referred from another hospital to our center, a
selection bias may have favored only relatively ﬁt patients
who could be transported. Furthermore, Boerhaave’s syn-
drome is a relatively rare condition, so only a small number
of patients could be included in our analysis. Still, the
morbidity of the 24 patients treated with nonresectional
debridement and drainage compares favorably with that of
series including resection. The absence of signiﬁcant dif-
ferences between VATS and treatment by thoracotomy in
our study may reﬂect the low number of patients included.
The rarity of the pathology limits the number of patients
that can be included in any prospective randomized study.
Therefore comparison of VATS and thoracotomy is pos-
sible only against a historical cohort.
In conclusion, spontaneous esophageal perforation
(Boerhaave’s syndrome) can be managed adequately with a
low mortality by debridement and drainage of the medi-
astinum and pleural cavity using thoracotomy or VATS.
More prospective studies are warranted to emphasize the
advantages of VATS in the treatment of this syndrome.
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